IL6 and Cognitive impairment: Specifically, the expression levels of the proinflammatory cytokines interleukin 1β (IL-1β) and interleukin 6 (IL-6) did not show any significant changes among the normal control healthy (NC), mild cognitive impairment (MCI) and dementia stage of AD patients (Table 2).